Multinationals companies (MNCs) in India have outperformed their Indian peers in the quarter ended December 2001.
The aggregate net profit of 71 MNCs increased by 16.3 per cent while 2,205 Indian companies have reported a 23 per cent decline. The sample of domestic companies excludes banks, non-bank finance companies and financial institutions.
But when it comes to topline growth, MNCs were as much hit by the slowdown as Indian companies. The 71 MNCs reported a 2 per cent growth in the topline (sales) during the quarter ended December 2001, while Indian companies reported a drop of 2.7 per cent.
The difference in financial performance is most pronounced in the personal care, electronics, pumps and compressors, and lubricants and food processing sectors. Interestingly, the pharmaceuticals sector had a very different story to tell in that Indian majors Ranbaxy Laboratories and Dr Reddy
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
